ArticleOpen forum infectious diseases2025

Clinical Outcomes and Perspectives of People With Human Immunodeficiency Virus Type 1 Twelve Months After Initiation of Long-acting Cabotegravir and Rilpivirine in an Observational Real-world US Study (BEYOND).

Dima Dandachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.